CMS Accepts More than 150 Providers, Digital Health Firms for ACCESS Model

Why It Matters

By establishing predictable, outcome‑based reimbursement, the ACCESS Model removes a major barrier for digital‑health innovators and could accelerate scalable solutions for America’s chronic disease epidemic.

Key Takeaways

• CMS approved 150+ providers and digital‑health firms for ACCESS.
• Payments range $7.50‑$35 per beneficiary monthly, outcome‑based.
• Model targets diabetes, kidney disease, hypertension, anxiety, depression.
• Companies like Noom, Verily, Whoop gain first Medicare access.
• Applications due May 15; later submissions may start Jan 1, 2027.

Pulse Analysis

The ACCESS Model represents CMS’s most ambitious foray into value‑based care for chronic disease, pairing fixed per‑beneficiary payments with strict outcome thresholds. By earmarking up to $35 per month for each enrollee who meets clinical targets, the program aims to align financial incentives with measurable health improvements, a shift from fee‑for‑service that could lower long‑term Medicare spending while improving patient outcomes. The model’s ten‑year horizon gives participants ample time to refine digital interventions and demonstrate sustained efficacy across conditions that account for a sizable share of U.S. healthcare costs.

For digital‑health firms, the announcement is a watershed moment. Historically, inconsistent payer reimbursement has stymied widespread adoption of remote monitoring tools, AI‑driven analytics, and wearable platforms. ACCESS offers a predictable revenue stream, encouraging companies like Noom, Verily and Whoop to integrate their solutions into Medicare’s care pathways. The modest per‑beneficiary rates are offset by the potential for scale—once a technology proves effective, it can be deployed across millions of seniors, generating recurring monthly payments that justify the upfront investment in regulatory compliance and integration.

Policy‑wise, the initiative dovetails with HHS Secretary Robert F. Kennedy Jr.’s broader agenda to combat chronic illness through systemic reforms in food and health systems. By incentivizing technology‑enabled management of diabetes, hypertension and mental health, ACCESS could serve as a template for future payer‑provider collaborations. However, success hinges on rigorous data collection, interoperability, and the ability of newcomers to navigate Medicare enrollment. If these hurdles are cleared, the model may reshape chronic care delivery and set a new standard for public‑private partnership in health innovation.